Stockscreener 앱 받기
0.9134
1.18%
0.00925
전일 마감가:
$0.9041
열려 있는:
$0.92
하루 거래량:
196.18K
Relative Volume:
0.20
시가총액:
$96.96M
수익:
$15.33M
순이익/손실:
$-34.78M
주가수익비율:
-2.2348
EPS:
-0.4087
순현금흐름:
$-28.66M
1주 성능:
+2.45%
1개월 성능:
-7.73%
6개월 성능:
-20.45%
1년 성능:
-25.63%
1일 변동 폭
$0.8801
$0.92
1주일 범위
$0.865
$0.93
52주 변동 폭
$0.85
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.9143 | 95.63M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
116.11 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.13 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.52 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.31 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - aol.com
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - Vinanet
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - Vinanet
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - Vinanet
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
Hyperfine Inc. (HYPR) Holds Near $0.95 as Shares Consolidate Between Key Support and ResistanceJurik MA - Vinanet
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine, Inc. (NASDAQ: HYPR) grows Q2 sales but remains unprofitable - Stock Titan
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M - Stock Titan
HYPR: Q2 2026 delivered robust revenue growth, margin expansion, and accelerated global adoption - TradingView
BRIEF-Hyperfine, Inc. Q2 EPS USD -0.09 - TradingView
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results - Business Wire
Earnings To Watch: Hyperfine Inc (HYPR) Q2 2026 -- GF Value Sees 72% Upside - Yahoo Finance
Hyperfine Inc. (HYPR) Climbs to $1.03 as Bullish Traders Test ResistanceGap and Reverse - dars.gov.et
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Hyperfine, Inc. Revenue Breakdown – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Gains 4.15% as Stock Tests Key Resistance at $0.98Day Trade Opportunities - Vinanet
Hyperfine Inc. (HYPR) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares SlideEarnings Trend Analysis - dars.gov.et
New Hyperfine Swoop® Portable MRI for Easier and Faster Stroke Visualization - marketscreener.com
BlackRock (NYSE: BLK) discloses 5.5% beneficial ownership in Hyperfine (HYPR) - Stock Titan
HYPR|Hyperfine Inc|Price:0.936|Chg%:+0.008 - TradingKey
Hyperfine Inc (HYPR) Institutional Confidence - TradingKey
Hyperfine Inc (HYPR) Balance Sheet - TradingKey
HYPR|Hyperfine Inc|Price:0.970|Chg%:+0.016 - TradingKey
Hyperfine Inc (HYPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Hyperfine Inc (HYPR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Hyperfine Inc (HYPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
자본화:
|
볼륨(24시간):